Advertisement
News
Advertisement

Boston Scientific Apologizes for Embargo Breach that Got Its Watchman Trial Pulled from Conference

Sat, 03/09/2013 - 11:16pm
Mass Device

American College of Cardiology conference organizers cancel the highly anticipated presentation of preliminary results from Boston Scientific's PREVAIL study after the company leaks the data ahead of time. Boston Scientific publishes the slides that would have been presented at this weekend's American College of Cardiology meeting had the company preserved the embargo on the findings.

American College of Cardiology conference 2013 logo

Medical device giant Boston Scientific (NYSE:BSX) did not present its highly anticipated PREVAIL clinical trial results at the American College of Cardiology conference as planned this weekend after the presentation was canceled when the company leaked the data ahead of time.

Boston Scientific leaked a press release to its investors Saturday morning, breaking an embargo on the study that was meant to be lifted during the presentation.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading